Afatinib Active Not Recruiting Phase 2 Trials for Lung Cancer Non-Small Cell Cancer (NSCLC) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01156545BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC
NCT01415011Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients
NCT01746251Adjuvant Afatinib in Stage I-III NSCLC With EGFR Mutation